Activist investor Carl Icahn, who is seeking representation on the board of Forest Laboratories Inc, said he is suing the U.S. drugmaker to obtain more information about its succession planning.
Icahn suing Forest, cites succession plan worries
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.